Benefits of coronary revascularisation in diabetic and non-diabetic patients with ischaemic cardiomyopathy: Role of myocardial viability

European Journal of Heart Failure

Volumn 8, Issue 3, 2006, Pages 314-320

  Rizzello, Vittoria ^b   Poldermans, Don ^a   Biagini, Elena ^a   Schinkel, Arend F L ^a   Boersma, Eric ^a   Elhendy, Abdou ^a   Sozzi, Fabiola B ^a   Maat, Alexander ^a   Roelandt, Jos R T C ^a   Bax, Jeroen J ^c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b CATHOLIC UNIVERSITY   (Italy)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Coronary artery disease; Coronary revascularisation; Diabetes mellitus; Ischaemic cardiomyopathy; Myocardial viability

Indexed keywords

DOBUTAMINE;

ADULT; AGED; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE REMODELING; HUMAN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; STRESS ECHOCARDIOGRAPHY; SURVIVAL;

AGED; DIABETES COMPLICATIONS; DOBUTAMINE; ECHOCARDIOGRAPHY, STRESS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 33646487424     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2005.07.014     Document Type: Article

References (35)

1. Ragosta M., Beller G.A., Watson D.D., et al. Quantitative planar rest-redistribution 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation 87 (1993) 1630-1641
2. Vanoverschelde J.L., Gerber B.L., D'Hondt A.M., et al. Preoperative selection of patients with severely impaired left ventricular function for coronary revascularization. Role of low-dose dobutamine echocardiography and exercise-redistribution-reinjection thallium SPECT. Circulation 92 (1995) II37-II44
3. Bax J.J., Poldermans D., Elhendy A., et al. Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. J Am Coll Cardiol 34 (1999) 163-169
4. Pasquet A., Lauer M.S., Williams M.J., et al. Prediction of global ventricular function after bypass surgery in patients with severe left ventricular dysfunction. Impact of pre-operative myocardial function, perfusion, and metabolism. Eur Heart J 21 (2000) 125-136
5. Pagano D., Bonser R.S., Townend J.N., et al. Predictive value of dobutamine echocardiography and positron emission tomography in identifying hibernating myocardium in patients with postischaemic heart failure. Heart 79 (1998) 281-288
6. Baker D.W., Jones R., Hodges J., et al. Management of heart failure. III. The role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction. JAMA 272 (1994) 1528-1534
7. Haas F., Haehnel C.J., Picker W., et al. Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease. J Am Coll Cardiol 30 (1997) 1693-1700
8. Kannel W.B., and McGee D.L. Diabetes and cardiovascular disease. The Framingham study. JAMA 241 (1979) 2035-2038
9. Shindler D.M., Kostis J.B., Yusuf S., et al. Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry. Am J Cardiol 77 (1996) 1017-1020
10. Devereux R.B., Roman M.J., Paranicas M., et al. Impact of diabetes on cardiac structure and function: the strong heart study. Circulation 101 (2000) 2271-2276
11. Stewart R.D., Campos C.T., Jennings B., et al. Predictors of 30-day hospital readmission after coronary artery bypass. Ann Thorac Surg 70 (2001) 169-174
12. Herlitz J., Wognsen G.B., Emanuelsson H., et al. Mortality and morbidity in diabetic and nondiabetic patients during a 2-year period after coronary artery bypass grafting. Diabetes Care 19 (1996) 698-703
13. Herlitz J., Caidahl K., Wiklund I., et al. Impact of a history of diabetes on the improvement of symptoms and quality of life during 5 years after coronary artery bypass grafting. J Diabetes Complications 14 (2000) 314-321
14. Schiller N.B., Shah P.M., Crawford M., et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2 (1989) 358-367
15. Salustri A., Ciavatti M., Seccareccia F., et al. Prediction of cardiac events after uncomplicated acute myocardial infarction by clinical variables and dobutamine stress test. J Am Coll Cardiol 34 (1999) 435-440
16. Arnese M., Cornel J.H., Salustri A., et al. Prediction of improvement of regional left ventricular function after surgical revascularization. A comparison of low-dose dobutamine echocardiography with 201Tl single-photon emission computed tomography. Circulation 91 (1995) 2748-2752
17. Afridi I., Kleiman N.S., Raizner A.E., et al. Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation 91 (1995) 663-670
18. Rizzello V., Poldermans D., Boersma E., et al. Opposite patterns of left ventricular remodeling after coronary revascularization in patients with ischemic cardiomyopathy: role of myocardial viability. Circulation 110 (2004) 2383-2388
19. Gheorghiade M., and Bonow R.O. Chronic heart failure in the United States: a manifestation of coronary artery disease. Circulation 97 (1998) 282-289
20. King H., Aubert R.E., and Herman W.H. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21 (1998) 1414-1431
21. Abbott R.D., Donahue R.P., Kannel W.B., et al. The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study. JAMA 260 (1988) 3456-3460
22. Shindler D.M., Kostis J.B., Yusuf S., et al. Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) Trials and Registry. Am J Cardiol 77 (1996) 1017-1020
23. McKelvie R.S., Yusuf S., Pericak D., et al. Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators. Circulation 100 (1999) 1056-1064
24. Haffner S.M. Coronary heart disease in patients with diabetes. N Engl J Med 342 (2000) 1040-1042
25. Poldermans D., Rambaldi R., Bax J.J., et al. Safety and utility of atropine addition during dobutamine stress echocardiography for the assessment of viable myocardium in patients with severe left ventricular dysfunction. Eur Heart J 19 (1998) 1712-1718
26. Schoder H., Campisi R., Ohtake T., et al. Blood flow-metabolism imaging with positron emission tomography in patients with diabetes mellitus for the assessment of reversible left ventricular contractile dysfunction. J Am Coll Cardiol 33 (1999) 1328-1337
27. Schinkel A.F., Bax J.J., Valkema R., et al. Effect of diabetes mellitus on myocardial 18F-FDG SPECT using acipimox for the assessment of myocardial viability. J Nucl Med 44 (2003) 877-883
28. Hamer A.W., Takayama M., Abraham K.A., et al. End-systolic volume and long-term survival after coronary artery bypass graft surgery in patients with impaired left ventricular function. Circulation 90 (1994) 2899-2904
29. Cleland J.G., Thygesen K., Uretsky B.F., et al. Cardiovascular critical event pathways for the progression of heart failure; a report from the ATLAS study. Eur Heart J 22 (2001) 1601-1612
30. St John Sutton M., Lee D., Rouleau J.L., et al. Left ventricular remodeling and ventricular arrhythmias after myocardial infarction. Circulation 107 (2003) 2577-2582
31. Groenning B.A., Nilsson J.C., Sondergaard L., et al. Antiremodeling effects on the left ventricle during beta-blockade with metoprolol in the treatment of chronic heart failure. J Am Coll Cardiol 36 (2000) 2072-2080
32. Sharpe N., and Doughty R.N. Left ventricular remodelling and improved long-term outcomes in chronic heart failure. Eur Heart J 19 Suppl B (1998) B36-B39
33. Allman K.C., Shaw L.J., Hachamovitch R., et al. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 39 (2002) 1151-1158
34. Pasquet A., Robert A., D'Hondt A.M., et al. Prognostic value of myocardial ischemia and viability in patients with chronic left ventricular ischemic dysfunction. Circulation 100 (1999) 141-148
35. Samady H., Elefteriades J.A., Abbott B.G., et al. Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worse outcome. Circulation 100 (1999) 1298-1304